Adverse reactions are now described on company websites, patient forums and social platforms long before they reach a safety department. EU good pharmacovigilance practice makes marketing authorisation holders responsible for the digital channels under their control, and expects a reasoned approach to the rest.
What the guidance requires
GVP Module VI says MAHs should regularly screen the internet or digital media under their management or responsibility for potential suspected adverse reactions. The frequency should allow valid individual case safety reports to be submitted within the regulatory time frames, counted from the date the information was posted. Unsolicited cases from these sources are handled as spontaneous reports.
Company-sponsored or not
For media that are not company-sponsored, the MAH should assess whether the report qualifies as a case. The guidance gives a useful clarification: a donation to a site does not make it company-sponsored unless the MAH controls the final content. Because the line is not always obvious, record the decision for each channel in a procedure.
When a post is a valid case
- Identifiable reporter: there must be evidence that the person exists. For internet cases, the guidance says a validly formatted email address can establish this. Where qualification is missing, the report defaults to a consumer report.
- Identifiable patient: at least one patient descriptor, such as initials, age, age group or gender, is needed. A report about an unspecified number of patients is not valid until an individual can be characterised.
- Suspect product and event: the two other minimum elements for any case.
Operational realities
- Comments on a company page can arrive overnight or on a holiday, so define who monitors, how often and what cover exists.
- Marketing and communications teams who run the accounts must be trained to forward potential cases to pharmacovigilance within a fixed time, and the training should be recorded.
- Agency partners and influencers working on behalf of the company need contractual safety obligations.
- Keep records of screening, including periods with no findings, so you can show the process worked.
Privacy and tone
Handling personal data seen on public posts requires data protection compliance, and replies from company accounts should not give medical advice. Standard wording directing the person to report through the proper channel is normally the safest approach.
How PQRA helps
PQRA can help define which channels fall under your responsibility, write the screening and escalation procedure, build the training for marketing, social media and agency teams and prepare the records that inspectors ask to see.
Contact PQRA to discuss your digital safety screening.


No responses yet